## **Core Concept**
Malignant melanoma is a type of skin cancer that originates from melanocytes. It is known for its aggressive behavior and potential to metastasize. Treatment options for malignant melanoma include surgery, chemotherapy, targeted therapy, and immunotherapy.

## **Why the Correct Answer is Right**
The correct answer involves understanding the current standard treatments for malignant melanoma. Surgery is often the primary treatment for localized melanoma. However, for advanced or metastatic melanoma, targeted therapies (e.g., BRAF and MEK inhibitors) and immunotherapies (e.g., checkpoint inhibitors like PD-1 and CTLA-4 inhibitors) have significantly improved outcomes.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because, although it might represent a treatment, without specifics, it's hard to judge its relevance or accuracy in the context of current melanoma treatment guidelines.
- **Option B:** Similarly, this option lacks specificity but generally, treatments for melanoma are more nuanced and involve a combination of the aforementioned therapies rather than a single, unspecified approach.
- **Option C:** This could potentially be a correct approach for some stages or types of melanoma but is often used in conjunction with other therapies.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **BRAF mutations** are present in about 50% of melanoma cases, and **BRAF inhibitors** (e.g., vemurafenib) combined with **MEK inhibitors** (e.g., trametinib) are a cornerstone in the treatment of metastatic melanoma with BRAF V600 mutations. Additionally, **immunotherapy** with checkpoint inhibitors has revolutionized the treatment of advanced melanoma.

## **Correct Answer:** D.